STAT1 activation in squamous cell cancer of the oral cavity

A potential predictive marker of response to adjuvant chemotherapy

Klaus Laimer, Gilbert Spizzo, Peter Obrist, Guenther Gastl, Thomas Brunhuber, Georg Schäfer, Burghard Norer, Michael Rasse, Michael C. Haffner, Wolfgang Doppler

Research output: Contribution to journalArticle

Abstract

BACKGROUND. For patients with squamous cell carcinoma of the oral cavity, both locoregional and distant recurrences are common, and an appropriate adjuvant treatment modality has yet to be defined. Thus, there is an urgent need to identify novel molecular markers with potential prognostic and/or predictive value to improve treatment outcome in these patients. This retrospective study was designed to investigate the predictive and/or prognostic value of STAT1 activation in squamous cell carcinoma of the oral cavity. METHODS. STAT1 expression and subcellular localization was examined immunohistochemically on a tissue microarray of paraffin-embedded tumor specimens from 89 patients who underwent surgical treatment in the period between 1980 and 1997. A nuclear staining score of greater than 35% was defined as high STAT1 activation. RESULTS. According to study criteria, 18% of analyzed tumor samples exhibited high STAT1 activation. High STAT1 activation was associated with negative lymph node status. Moreover, in the subgroup of patients who received chemotherapy, high nuclear STAT1 staining in the tumor was associated with good prognosis. CONCLUSIONS. This is the first report demonstrating the potential predictive value of STAT1 activation status in patients with squamous cell cancer of the oral cavity. If confirmed in large prospective trials, this molecular marker could help in guiding therapeutic decisions in these patients.

Original languageEnglish (US)
Pages (from-to)326-333
Number of pages8
JournalCancer
Volume110
Issue number2
DOIs
StatePublished - Jul 15 2007
Externally publishedYes

Fingerprint

Squamous Cell Neoplasms
Mouth Neoplasms
Adjuvant Chemotherapy
Mouth
Squamous Cell Carcinoma
Staining and Labeling
Neoplasms
Paraffin
Therapeutics
Retrospective Studies
Lymph Nodes
Recurrence
Drug Therapy

Keywords

  • Chemotherapy
  • Oral squamous cell carcinoma
  • Predictive marker
  • STAT1
  • Tissue microarray

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Laimer, K., Spizzo, G., Obrist, P., Gastl, G., Brunhuber, T., Schäfer, G., ... Doppler, W. (2007). STAT1 activation in squamous cell cancer of the oral cavity: A potential predictive marker of response to adjuvant chemotherapy. Cancer, 110(2), 326-333. https://doi.org/10.1002/cncr.22813

STAT1 activation in squamous cell cancer of the oral cavity : A potential predictive marker of response to adjuvant chemotherapy. / Laimer, Klaus; Spizzo, Gilbert; Obrist, Peter; Gastl, Guenther; Brunhuber, Thomas; Schäfer, Georg; Norer, Burghard; Rasse, Michael; Haffner, Michael C.; Doppler, Wolfgang.

In: Cancer, Vol. 110, No. 2, 15.07.2007, p. 326-333.

Research output: Contribution to journalArticle

Laimer, K, Spizzo, G, Obrist, P, Gastl, G, Brunhuber, T, Schäfer, G, Norer, B, Rasse, M, Haffner, MC & Doppler, W 2007, 'STAT1 activation in squamous cell cancer of the oral cavity: A potential predictive marker of response to adjuvant chemotherapy', Cancer, vol. 110, no. 2, pp. 326-333. https://doi.org/10.1002/cncr.22813
Laimer, Klaus ; Spizzo, Gilbert ; Obrist, Peter ; Gastl, Guenther ; Brunhuber, Thomas ; Schäfer, Georg ; Norer, Burghard ; Rasse, Michael ; Haffner, Michael C. ; Doppler, Wolfgang. / STAT1 activation in squamous cell cancer of the oral cavity : A potential predictive marker of response to adjuvant chemotherapy. In: Cancer. 2007 ; Vol. 110, No. 2. pp. 326-333.
@article{e193f56c7e5342e3838eb019b72a60de,
title = "STAT1 activation in squamous cell cancer of the oral cavity: A potential predictive marker of response to adjuvant chemotherapy",
abstract = "BACKGROUND. For patients with squamous cell carcinoma of the oral cavity, both locoregional and distant recurrences are common, and an appropriate adjuvant treatment modality has yet to be defined. Thus, there is an urgent need to identify novel molecular markers with potential prognostic and/or predictive value to improve treatment outcome in these patients. This retrospective study was designed to investigate the predictive and/or prognostic value of STAT1 activation in squamous cell carcinoma of the oral cavity. METHODS. STAT1 expression and subcellular localization was examined immunohistochemically on a tissue microarray of paraffin-embedded tumor specimens from 89 patients who underwent surgical treatment in the period between 1980 and 1997. A nuclear staining score of greater than 35{\%} was defined as high STAT1 activation. RESULTS. According to study criteria, 18{\%} of analyzed tumor samples exhibited high STAT1 activation. High STAT1 activation was associated with negative lymph node status. Moreover, in the subgroup of patients who received chemotherapy, high nuclear STAT1 staining in the tumor was associated with good prognosis. CONCLUSIONS. This is the first report demonstrating the potential predictive value of STAT1 activation status in patients with squamous cell cancer of the oral cavity. If confirmed in large prospective trials, this molecular marker could help in guiding therapeutic decisions in these patients.",
keywords = "Chemotherapy, Oral squamous cell carcinoma, Predictive marker, STAT1, Tissue microarray",
author = "Klaus Laimer and Gilbert Spizzo and Peter Obrist and Guenther Gastl and Thomas Brunhuber and Georg Sch{\"a}fer and Burghard Norer and Michael Rasse and Haffner, {Michael C.} and Wolfgang Doppler",
year = "2007",
month = "7",
day = "15",
doi = "10.1002/cncr.22813",
language = "English (US)",
volume = "110",
pages = "326--333",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - STAT1 activation in squamous cell cancer of the oral cavity

T2 - A potential predictive marker of response to adjuvant chemotherapy

AU - Laimer, Klaus

AU - Spizzo, Gilbert

AU - Obrist, Peter

AU - Gastl, Guenther

AU - Brunhuber, Thomas

AU - Schäfer, Georg

AU - Norer, Burghard

AU - Rasse, Michael

AU - Haffner, Michael C.

AU - Doppler, Wolfgang

PY - 2007/7/15

Y1 - 2007/7/15

N2 - BACKGROUND. For patients with squamous cell carcinoma of the oral cavity, both locoregional and distant recurrences are common, and an appropriate adjuvant treatment modality has yet to be defined. Thus, there is an urgent need to identify novel molecular markers with potential prognostic and/or predictive value to improve treatment outcome in these patients. This retrospective study was designed to investigate the predictive and/or prognostic value of STAT1 activation in squamous cell carcinoma of the oral cavity. METHODS. STAT1 expression and subcellular localization was examined immunohistochemically on a tissue microarray of paraffin-embedded tumor specimens from 89 patients who underwent surgical treatment in the period between 1980 and 1997. A nuclear staining score of greater than 35% was defined as high STAT1 activation. RESULTS. According to study criteria, 18% of analyzed tumor samples exhibited high STAT1 activation. High STAT1 activation was associated with negative lymph node status. Moreover, in the subgroup of patients who received chemotherapy, high nuclear STAT1 staining in the tumor was associated with good prognosis. CONCLUSIONS. This is the first report demonstrating the potential predictive value of STAT1 activation status in patients with squamous cell cancer of the oral cavity. If confirmed in large prospective trials, this molecular marker could help in guiding therapeutic decisions in these patients.

AB - BACKGROUND. For patients with squamous cell carcinoma of the oral cavity, both locoregional and distant recurrences are common, and an appropriate adjuvant treatment modality has yet to be defined. Thus, there is an urgent need to identify novel molecular markers with potential prognostic and/or predictive value to improve treatment outcome in these patients. This retrospective study was designed to investigate the predictive and/or prognostic value of STAT1 activation in squamous cell carcinoma of the oral cavity. METHODS. STAT1 expression and subcellular localization was examined immunohistochemically on a tissue microarray of paraffin-embedded tumor specimens from 89 patients who underwent surgical treatment in the period between 1980 and 1997. A nuclear staining score of greater than 35% was defined as high STAT1 activation. RESULTS. According to study criteria, 18% of analyzed tumor samples exhibited high STAT1 activation. High STAT1 activation was associated with negative lymph node status. Moreover, in the subgroup of patients who received chemotherapy, high nuclear STAT1 staining in the tumor was associated with good prognosis. CONCLUSIONS. This is the first report demonstrating the potential predictive value of STAT1 activation status in patients with squamous cell cancer of the oral cavity. If confirmed in large prospective trials, this molecular marker could help in guiding therapeutic decisions in these patients.

KW - Chemotherapy

KW - Oral squamous cell carcinoma

KW - Predictive marker

KW - STAT1

KW - Tissue microarray

UR - http://www.scopus.com/inward/record.url?scp=34547217598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547217598&partnerID=8YFLogxK

U2 - 10.1002/cncr.22813

DO - 10.1002/cncr.22813

M3 - Article

VL - 110

SP - 326

EP - 333

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2

ER -